Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05118724
Title Atezolizumab With/Without IMM-101 in Patients With MSI-h/MMR-D Stage III Colorectal Cancer Ineligible for Oxaliplatin (ANTONIO)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AIO-Studien-gGmbH
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Atezolizumab

Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Westdeutsches Tumorzentrum Recruiting Essen 45147 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field